Εμφάνιση απλής εγγραφής

dc.creatorZintzaras, E.en
dc.creatorRaman, G.en
dc.creatorKitsios, G.en
dc.creatorLau, J.en
dc.date.accessioned2015-11-23T10:55:16Z
dc.date.available2015-11-23T10:55:16Z
dc.date.issued2008
dc.identifier10.1001/archinte.168.10.1077
dc.identifier.issn0003-9926
dc.identifier.urihttp://hdl.handle.net/11615/34973
dc.description.abstractBackground: Many studies have investigated the association between the angiotensin-converting enzyme (ACE) gene insertion(I)/deletion (D) polymorphic variant and coronary artery disease (CAD). However, the evidence is inadequate to draw robust conclusions because most studies were generally small and conducted in heterogeneous samples. To shed light on these inconclusive findings, we conducted a meta-analysis of studies relating the ACE I/D polymorphic variant to the risk of CAD. Methods: We searched the PubMed database for English-language articles on CAD in humans. We estimated summary odds ratios and explored potential sources of heterogeneity and bias. Results: The 118 studies chosen for the analysis involved 43 733 cases with CAD and 82 606 controls. The heterogeneity between studies was significant. When we compared homozygotes with the D and I alterations, the ACE I/D polymorphic variant was associated with a 25% increased risk of CAD (odds ratio, 1.25; 95% confidence interval, 1.16-1.35). Subgroup analyses for myocardial infarction, diabetes mellitus, male sex, white race, East Asian subjects, and Turkish subjects showed significant associations. No association was found in other racial/ethnic groups, in women, in premature cases, or in cases with low levels of risk factors. The major sources of heterogeneity were due to racial/ethnic diversity, genotyping procedure, and age matching. Cumulative meta-analysis for the allelic contrast showed a trend of association as information accumulated. There was a differential magnitude of effect in large vs small studies. Conclusions: The meta-analysis demonstrated evidence of a modest positive association between ACE I/D polymorphic variant and CAD. The meta-analysis also highlights the heterogeneity of reported results, considerable gaps in research, and the need for future studies focused on certain high-risk patient populations.en
dc.sourceArchives of Internal Medicineen
dc.source.uri<Go to ISI>://WOS:000256057000009
dc.subjectMETHYLENETETRAHYDROFOLATE REDUCTASE GENEen
dc.subjectISCHEMIC-HEART-DISEASEen
dc.subjectIIen
dc.subjectTYPE-1 RECEPTORen
dc.subjectPREMATURE MYOCARDIAL-INFARCTIONen
dc.subjectDEPENDENTen
dc.subjectDIABETES-MELLITUSen
dc.subjectNITRIC-OXIDE SYNTHASEen
dc.subjectHETEROZYGOUS FAMILIALen
dc.subjectHYPERCHOLESTEROLEMIAen
dc.subjectRANDOMIZED CONTROLLED-TRIALSen
dc.subjectNEUROTROPHIC FACTORen
dc.subjectGENEen
dc.subjectACE-DD GENOTYPEen
dc.subjectMedicine, General & Internalen
dc.titleAngiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease - A meta-analysisen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής